Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,040.00
Bid: 12,040.00
Ask: 12,042.00
Change: -116.00 (-0.95%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,098.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday preview: Astrazeneca to report decline in third quarter sales

Wed, 09th Nov 2016 12:31

(ShareCast News) - Astrazeneca is expected to report a drop in third quarter sales on Thursday after failing to prevent generic drug makers from bringing cheaper rivals of its best-selling medicine Crestor.Analysts expect generic versions of cholesterol fighting drug Crestor will have sent revenue down 1% to $5.87bn in the three months to September, down from $5.95bn a year earlier. The group is expected to reveal net income of $731m, down 5% from the $770m the previous year.Deutsche Bank expects product sales to decline by 10% at a constant exchange rate and core earnings per share to drop about 4%, due to the erosion of Crestor and divestments.Generic versions of heartburn medicine Nexium are also expected to have provided a drag. Astrazeneca is looking to boost sales growth with new drugs, including blood-thinner Brilinta and Tagrisso for lung cancer. Deutsche Bank said Tagrisso should benefit from continued US growth and its recent launch in Japan.The bank also sees Brilinta continuing to show solid growth with US prescriptions increasing 40% year-on-year.Deutsche Bank added that risks to Astrazeneca include failure to deliver cost savings, lower platform sales, pipeline failure and a fall in sales of pipeline drugs.Meanwhile, investors will be looking for an update following's last month's setback on its experimental cancer medicine duralumab. The company suspended recruitment for two large clinical trials on durvalumab while it investigates some instances of bleeding among participants. Thursday 10 November INTERIMS Auto Trader Group , Dairy Crest Group, Halfords Group, Mediclinic International , Mercia Technologies , National Grid, Vedanta Resources INTERIM DIVIDEND PAYMENT DATE British American Inv Trust, Ladbrokes Coral Group, Scisys INTERIM EX-DIVIDEND DATE First Derivatives, Hadrian's Wall Secured Investments, London Security, NB Distressed Debt Investment Fund Limited, NB Distressed Debt Investment Fund Limited Ext Shs, NB Distressed Debt Investment Fund Limited Red Ord, Panther Securities, Whitbread QUARTERLY PAYMENT DATE Merchants Trust QUARTERLY EX-DIVIDEND DATE Boeing Co, BP, Brunner Inv Trust, F&C Commercial Property Trust Ltd., Royal Dutch Shell 'A', Royal Dutch Shell 'B' INTERNATIONAL ECONOMIC ANNOUNCEMENTS Continuing Claims (US) (13:30) Crude Oil Inventories (US) (15:30) Initial Jobless Claims (US) (13:30) Q3 AstraZeneca, Bank Pekao SA GDS (Reg S), Hellenic Telecom Industries SA ADS FINALS Mobile Streams SPECIAL DIVIDEND PAYMENT DATE Photo-Me International AGMS Swallowfield, Target Healthcare Reit Ltd, Tlou Energy Limited (DI), Urals Energy Public Co Ltd. (DI) TRADING ANNOUNCEMENTS Gem Diamonds Ltd. (DI), Howden Joinery Group FINAL DIVIDEND PAYMENT DATE Photo-Me International FINAL EX-DIVIDEND DATE Abcam, Craneware, DX (Group), Go-Ahead Group, JPMorgan Smaller Companies Inv Trust, Jupiter European Opportunities Trust, Revolution Bars Group, Swallowfield
More News
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.